COMMUNIQUÉ RÉGLEMENTÉ
News
-
-
COMMUNIQUÉ RÉGLEMENTÉ
KURMA PARTNERS, A MEMBER OF THE EURAZEO GROUP AND FOUNDING INVESTOR OF IMCHECK THERAPEUTICS, ANNOUNCES THE SALE OF THE BIOTECH COMPANY TO IPSEN FOR UP TO €1 BILLION
Kurma Partners, a member of the Eurazeo group, announces the sale of ImCheck Therapeutics to Ipsen for up to €1 billion. The biotech company focuses on immunotherapy for cancer treatment, confirming Kurma's success in creating and supporting biotech ventures -
-
COMMUNIQUÉ DE PRESSE
Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance
Ipsen reports strong sales growth in first nine months of 2025, upgrades full-year guidance, and announces acquisition of ImCheck Therapeutics. Financial results and pipeline updates detailed -
-
-
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Chiffre d’affaires du 3e trimestre 2025 d'OPmobility
OPmobility enregistre une solide croissance organique du chiffre d'affaires de +2,6% au 3e trimestre et confirme ses objectifs pour 2025. Activités en hausse en Amérique du Nord et en Asie. Adaptation rapide au contexte volatil -
